These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8687111)

  • 1. Selective induction of mucosal immune responses to 2-acetylaminofluorene.
    Silbart LK; McAleer F; Rasmussen MV; Goslinoski L; Keren DF; Finley A; Van Kruiningen HJ; Winchell JM
    Anticancer Res; 1996; 16(2):651-60. PubMed ID: 8687111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the mucosal immune response to 2-acetylaminofluorene-protein conjugates.
    Silbart LK; Keren DF; McDonald RA; Lincoln PM; Goslinoski L; Smart JB
    Reg Immunol; 1992; 4(4):245-54. PubMed ID: 1476877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.
    Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
    Am J Trop Med Hyg; 1994; 50(5 Suppl):42-54. PubMed ID: 8203723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of intestinal carcinogen absorption by carcinogen-specific secretory immunity.
    Silbart LK; Keren DF
    Science; 1989 Mar; 243(4897):1462-4. PubMed ID: 2928780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of J chain inhibits the transport of gut IgA and abrogates the development of intestinal antitoxic protection.
    Lycke N; Erlandsson L; Ekman L; Schön K; Leanderson T
    J Immunol; 1999 Jul; 163(2):913-9. PubMed ID: 10395687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholera toxin B subunit as a carrier protein to stimulate a mucosal immune response.
    McKenzie SJ; Halsey JF
    J Immunol; 1984 Oct; 133(4):1818-24. PubMed ID: 6470484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunodulation of rat serum and mucosal antibody responses to Entamoeba histolytica trophozoites by beta-1,3-glucan and cholera toxin.
    Navarro-García F; Pedroso M; López-Revilla R
    Clin Immunol; 2000 Nov; 97(2):182-8. PubMed ID: 11027459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A proposal for safety standards for human use of cholera toxin (or Escherichia coli heat-labile enterotoxin) derivatives as an adjuvant of nasal inactivated influenza vaccine.
    Tamura SI; Kurata T
    Jpn J Infect Dis; 2000 Jun; 53(3):98-106. PubMed ID: 10957706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rice-based oral cholera vaccine induces macaque-specific systemic neutralizing antibodies but does not influence pre-existing intestinal immunity.
    Nochi T; Yuki Y; Katakai Y; Shibata H; Tokuhara D; Mejima M; Kurokawa S; Takahashi Y; Nakanishi U; Ono F; Mimuro H; Sasakawa C; Takaiwa F; Terao K; Kiyono H
    J Immunol; 2009 Nov; 183(10):6538-44. PubMed ID: 19880451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal sublingual vaccination with Salmonella proteins and adjuvant cholera toxin or CpG oligodeoxynucleotides induces mucosal and systemic immunity in mice.
    Huang CF; Wang CC; Wu TC; Wu KG; Lee CC; Peng HJ
    J Pediatr Gastroenterol Nutr; 2008 Mar; 46(3):262-71. PubMed ID: 18376242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
    Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral immune responses by prime-boost heterologous route immunizations with CTB-MPR(649-684), a mucosal subunit HIV/AIDS vaccine candidate.
    Matoba N; Geyer BC; Kilbourne J; Alfsen A; Bomsel M; Mor TS
    Vaccine; 2006 Jun; 24(23):5047-55. PubMed ID: 16621185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative evaluation of nasal and parenteral vaccine adjuvants to elicit systemic and mucosal HIV-1 peptide-specific humoral immune responses in cynomolgus macaques.
    Egan MA; Chong SY; Hagen M; Megati S; Schadeck EB; Piacente P; Ma BJ; Montefiori DC; Haynes BF; Israel ZR; Eldridge JH; Staats HF
    Vaccine; 2004 Sep; 22(27-28):3774-88. PubMed ID: 15315859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of immune responses and prevention of alveolar bone loss by intranasal administration of mice with Porphyromonas gingivalis fimbriae and recombinant cholera toxin B subunit.
    Takahashi Y; Kumada H; Hamada N; Haishima Y; Ozono S; Isaka M; Yasuda Y; Tochikubo K; Umemoto T
    Oral Microbiol Immunol; 2007 Dec; 22(6):374-80. PubMed ID: 17949339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphological and immune response alterations in the intestinal mucosa of the mouse after short periods on a low-magnesium diet.
    Zimowska W; Girardeau JP; Kuryszko J; Bayle D; Rayssiguier Y; Mazur A
    Br J Nutr; 2002 Nov; 88(5):515-22. PubMed ID: 12425732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA.
    Holmgren J; Adamsson J; Anjuère F; Clemens J; Czerkinsky C; Eriksson K; Flach CF; George-Chandy A; Harandi AM; Lebens M; Lehner T; Lindblad M; Nygren E; Raghavan S; Sanchez J; Stanford M; Sun JB; Svennerholm AM; Tengvall S
    Immunol Lett; 2005 Mar; 97(2):181-8. PubMed ID: 15752556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compartmentalization of the mucosal immune responses to commensal intestinal bacteria.
    Macpherson AJ; Uhr T
    Ann N Y Acad Sci; 2004 Dec; 1029():36-43. PubMed ID: 15681741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic and intestinal antibody responses to NSP4 enterotoxin of Wa human rotavirus in a gnotobiotic pig model of human rotavirus disease.
    Iosef C; Chang KO; Azevedo MS; Saif LJ
    J Med Virol; 2002 Sep; 68(1):119-28. PubMed ID: 12210439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of secretory IgA on transepithelial passage of bacteria across the intact ileum in vitro.
    Albanese CT; Smith SD; Watkins S; Kurkchubasche A; Simmons RL; Rowe MI
    J Am Coll Surg; 1994 Dec; 179(6):679-88. PubMed ID: 7952481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoid regulation of the humoral immune system. I. In vivo effects of dexamethasone on IgA and IgG in serum and at mucosal surfaces.
    Wira CR; Sandoe CP; Steele MG
    J Immunol; 1990 Jan; 144(1):142-6. PubMed ID: 2295788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.